Thus, our data clearly indicate that the TGF-β signaling in CD4+ T cells and specifically Th17 cells is critical for the emergence of IL-22 producing Th17 cells and for the promotion of CRC in an IL-22-dependent manner. The gene discussed is TGFB1; the disease is colorectal carcinoma.